The Food and Drug Administration label for semaglutide the active ingredient in many weight loss drugs says it may increase the risk of bone fractures in older adults and women
For example, the weight loss version of Semaglutide injection (Novo Ying) has been approved in China for reducing the risk of major adverse cardiovascular events in adult patients with established cardiovascular disease and a body mass index (BMI) 27 kg/m
They also come with cost, access barriers, and potential side effects
The use of the glucagon-like peptide-1 receptor agonist (GLP-1RA), semaglutide, significantly enhanced liver health in patients with metabolic dysfunction-associated steatohepatitis (MASH) in several ways, including reducing inflammation, metabolic dysfunction, and fibrosis progression, through both weight-dependent and distinct proteomic mechanisms, according to a study published in Nature Medicine
Bergenstal, R.M., et al
One exception to this is the G-rich loop of CDK11 (residues 445450, sequence EEGTYG), which exhibits weak density, indicating flexibility